These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 33259899)
1. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4. Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899 [TBL] [Abstract][Full Text] [Related]
2. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. Ni W; Zhang Y; Zhan Z; Ye F; Liang Y; Huang J; Chen K; Chen L; Ding Y J Hematol Oncol; 2017 Apr; 10(1):91. PubMed ID: 28420424 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis. Fang QL; Zhou JY; Xiong Y; Xie CR; Wang FQ; Li YT; Yin ZY; Luo GH Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32100822 [TBL] [Abstract][Full Text] [Related]
4. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression. Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238 [TBL] [Abstract][Full Text] [Related]
5. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
6. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling. Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma. Zhou Q; Zhang W; Wang Z; Liu S BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767 [TBL] [Abstract][Full Text] [Related]
8. RP11-81H3.2 Acts as an Oncogene via microRNA-490-3p Inhibition and Consequential Tankyrase 2 Up-Regulation in Hepatocellular Carcinoma. Chen W; Li K; Zhu K; Yan R; Cai QC; Li WH; Dang CX Dig Dis Sci; 2020 Oct; 65(10):2949-2958. PubMed ID: 31858324 [TBL] [Abstract][Full Text] [Related]
9. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway. Li J; Xia T; Cao J; He D; Chen Z; Liang B; Song J Aging (Albany NY); 2020 Jul; 12(14):14918-14932. PubMed ID: 32687483 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
12. Tumor Promoting Effect of Long Non-Coding RNA RP11-556E13.1 and its Clinical Significance in Hepatocellular Carcinoma. Li J; Qiu X; Liu Z; Wang J; Wei Q; Zheng S; Xu X; Wang K Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345971 [TBL] [Abstract][Full Text] [Related]
13. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex. Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907 [TBL] [Abstract][Full Text] [Related]
14. Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced in Hepatocellular Carcinoma. Xu F; Li CH; Wong CH; Chen GG; Lai PBS; Shao S; Chan SL; Chen Y Cancer Res; 2019 Apr; 79(7):1305-1317. PubMed ID: 30718359 [TBL] [Abstract][Full Text] [Related]
15. Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma. Wang RY; Yang JL; Xu N; Xu J; Yang SH; Liang DM; Li JZ; Zhu H World J Gastroenterol; 2024 Feb; 30(8):919-942. PubMed ID: 38516243 [TBL] [Abstract][Full Text] [Related]
16. LncRNA RP11-620J15.3 promotes HCC cell proliferation and metastasis by targeting miR-326/GPI to enhance glycolysis. Liu C; Xu K; Liu J; He C; Liu P; Fu Q; Zhang H; Qin T Biol Direct; 2023 Apr; 18(1):15. PubMed ID: 37020316 [TBL] [Abstract][Full Text] [Related]
17. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761 [TBL] [Abstract][Full Text] [Related]
19. A novel long noncoding RNA HHIP-AS1 suppresses hepatocellular carcinoma progression through stabilizing HHIP mRNA. Bo C; Li X; He L; Zhang S; Li N; An Y Biochem Biophys Res Commun; 2019 Dec; 520(2):333-340. PubMed ID: 31604528 [TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway. Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]